Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Enalapril maleate 5mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Enalapril maleate 10mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Enalapril maleate 20mg
Tablet
Ipca Pharma (NZ) Pty Limited
Ipca Laboratories Limited, Silvassa, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
IPCA-Enalapril
Alemtuzumab 10mg/mL
Concentrate for infusion
Sanofi-Aventis New Zealand Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
|
Dated this 31st day of May 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz